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Biopolymer self-assembly pathways are central to biological activity, but are complicated by the
ability of the monomeric subunits of biopolymers to adopt different conformational states. As a re-
sult, biopolymer nucleation often involves a two-step mechanism where the monomers first condense
to form a metastable intermediate, and this then converts to a stable polymer by conformational re-
arrangement of its constituent monomers. While existing mathematical models neglect the dynamics
by which intermediates convert to stable polymers, experiments and simulations show that these
dynamics frequently occur on comparable timescales to condensation of intermediates and growth of
mature polymers, and thus cannot be ignored. Moreover, nucleation intermediates are responsible
for cell toxicity in numerous diseases, such as Alzheimer’s, Parkinson’s, and prion diseases. Due
to the relationship between conformation and biological function, the slow conversion dynamics of
these species will strongly affect their toxicity. In this study, we present a modified Oosawa model
which explicitly accounts for simultaneous assembly and conversion. To describe the conversion
dynamics, we propose an experimentally motivated initiation-propagation (IP) mechanism in which
the stable phase arises locally within the intermediate, and then spreads through additional con-
version events induced by nearest-neighbor interactions, in a manner analogous to one-dimensional
Glauber dynamics. Our mathematical analysis shows that the competing timescales of assembly
and conversion result in a nonequilibrium critical point, separating a regime where intermediates
are kinetically unstable from one where conformationally mixed intermediates can accumulate. In
turn, this strongly affects the rate at which the stable biopolymer phase accumulates. In contrast
to existing models, this model is able to reproduce commonly observed experimental phenomena
such as the formation of mixed intermediates, and abrupt changes in the scaling exponent γ, which
relates the total monomer concentration to the accumulation rate of the stable phase. Our work
provides the first step towards a general model of two-step biopolymer nucleation, which can be used
to quantitatively predict the concentration and composition of biologically crucial intermediates.
I. INTRODUCTION
Biopolymer formation is essential to life. Uncon-
trolled self-association of biological molecules to form
non-covalent polymers is implicated in diseases such as
Alzheimer’s [1], Parkinson’s [2], and sickle-cell anemia [3].
In many cases, the monomeric subunits of biopolymers
adopt distinct conformational states. As a result, nucle-
ation often proceeds via a two-step mechanism, in which
the monomers first condense into a metastable interme-
diate, and the stable polymer develops by conformational
conversion of the monomers within this phase [4–10]. In-
termediates have diverse morphologies (Fig. 1(a)), de-
pending on the monomer interactions which drive con-
densation. Polymeric intermediates are commonly ob-
served in experimental and computational studies of
amyloid formation [4, 11–13], and convert to stable poly-
mers via reorganization of their secondary or tertiary
structure. In addition, diverse biopolymers including
actin and prions are known to nucleate in spheroidal
intermediates [5–7, 10, 14–16]. Biopolymer nucleation
intermediates are implicated in cell death and resulting
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disease [17, 18], and an understanding of their formation
is crucial for therapeutic development.
In order to accurately predict the rate and mecha-
nism of two-step biopolymer nucleation, theoretical mod-
els must realistically represent the process by which in-
termediates convert to stable polymers. Existing ana-
lytical models treat conversion as an instantaneous pro-
cess [19–23], neglecting the dynamics by which the sta-
ble polymeric phase spreads through the intermediate.
However, there is no general reason why the ordering
transition should be sufficiently rapid, or cooperative, for
this to be valid. In contrast, experimental and computa-
tional studies often point to progressive ordering on slow
timescales [7, 15, 24–27], indicating that the stable phase
arises locally and spreads through the intermediate. This
means that condensation and ordering can occur concur-
rently [15, 24–26]. In addition, simulations support an
autocatalytic mechanism by which conformationally or-
dered monomers promote conversion of their neighbors
[24, 28, 29]. This raises the possibility that condensation
and ordering may be kinetically coupled, with larger in-
termediates converting at a higher rate [20, 22]; however,
the kinetic prerequisites for such a mechanism have not
been rigorously determined. Thus, in order to describe
the time-evolution of intermediate populations and elu-
cidate the role of autocatalysis in two-step nucleation,
there is an urgent requirement for a model which ex-
plicitly considers the conversion of intermediates by an
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2autocatalytic initiation-propagation (IP) mechanism.
In this paper, we address these issues. We develop
a minimal model of two-step nucleation (Fig. 1(b)-(f))
in which polymeric intermediates undergo an autocat-
alytic conversion process analogous to one-dimensional
(1D) Glauber dynamics [30]. Through a combination
of analytical calculations and stochastic simulations [31],
we show that this simple addition to Oosawa’s classi-
cal model of nucleated polymerization [32, 33] produces
rich, nonlinear dynamics. In autocatalytic systems, a
nonequilibrium critical point arises, separating a regime
where intermediates do not accumulate from one where
the two-step nature of nucleation becomes apparent. In
the vicinity of this critical point, nucleation dynamics
resemble a second-order phase transition similar to the
two-dimensional (2D) Ising model [34, 35]. It is clear
from our derivation that this phase transition does not
require a particular dimensionality, and we expect our
results to be applicable to morphologically diverse in-
termediates. Thus, we propose that models of explicit
conformational conversion have the capacity to reconcile
apparently contradictory interpretations of biopolymer
nucleation, and resolve important unanswered questions
regarding the origin and nature of metastable intermedi-
ates.
II. OUTLINE OF THE MODEL
In this section, we outline the mathematical basis
of our two-step biopolymer nucleation model. This
model combines the established formalism for nucle-
ated biopolymer self-assembly [32, 33] with a proposed
initiation-propagation (IP) mechanism of conformational
conversion, in which the stable phase arises locally
within the intermediate and spreads autocatalytically
by nearest-neighbor interactions (Fig. 1). In this re-
spect, our IP mechanism resembles 1D Glauber dynamics
[30]. Although the proposed dynamics affect all polymer-
ized monomers, we are particularly interested in their
effects on macroscopic, observable nucleated polymer-
ization. Therefore, we concentrate on the aspects of
these dynamics which are most relevant to the biopoly-
mer nucleation and growth, and leave a more comprehen-
sive treatment of the internal composition of developing
biopolymers as a subject for future work.
A. Microscopic processes
We consider nucleated polymerization of a free
monomer population maintained at a fixed concentration
m0, far from equilibrium. This situation arises physiolog-
ically, when there is a monomer source, and is also valid
for experimental systems on timescales shorter than the
typical timescale τinf for significant monomer depletion
to occur, which we discuss in greater detail in Sec. II. B.
Each biopolymer is treated as a 1D lattice of monomers
FIG. 1. Schematic of the proposed two-step biopoly-
mer nucleation model. (a) Biopolymer nucleation pathways
frequently involve diverse metastable intermediates, which
progress to stable polymers by conversion of monomer sub-
units. (b-f) Schematic representation of our model, account-
ing for explicit growth and conversion of linear intermediates
as described in Sec. II. A. Color scheme for monomers: green,
unassembled; red, metastable (type-1); blue, stable (type-2).
with length j. A polymerized monomer is in either the
metastable (type-1) or stable (type-2) state (Fig. 1(b)-
(f)). Polymerization is initiated at a rate vn = knm
j0
0 ,
and each polymer initially contains j0 ≥ 2 monomers in
the type-1 state (Fig. 1(b)). Polymerized monomers ir-
reversibly convert to the type-2 state at a rate of kc, or
kc+kp if adjacent to a type-2 monomer (Fig. 1(e) & (f)).
Thus, kp represents the excess rate due to autocatalysis.
For the purpose of this study, it is not necessary to con-
sider cases where a type-1 monomer is bounded by two
type-2 monomers, as such cases do not affect the macro-
scopic kinetics of nucleated polymerization.
Each polymer can elongate by reversible monomer ad-
dition at a single ‘active’ end (Fig. 1(c) & (d)). Strong
bias towards elongation at a single end is often observed
experimentally [36–38], and is caused by the fact that
most biopolymers exhibit structural differences between
their ends, which result in contrasting physicochemical
properties. Although inclusion of this bias simplifies our
analysis, it is not expected to qualitatively alter the re-
sults. Therefore, we fully expect our theory to generalize
to more unusual cases [39] where both ends elongate at
similar rates. It is also important to note that the for-
ward and reverse elongation rates must exhibit an equal
bias, in order to satisfy detailed balance when m0 is at
the solubility limit. From this point onwards, we sim-
ply refer to the forward process as elongation, and the
reverse process as dissociation.
During elongation, the conformational state of the
3monomer being incorporated into the polymer is tem-
plated by that of the monomer already at the active end
[5, 40] (Fig. 1(c) & (d)). Therefore, if the monomer at
the active end is in the type-1 state, then elongation
proceeds via addition of type-1 monomers with a for-
ward rate k+1 m0 and a reverse rate k
−
1 . Similarly, if the
monomer at the active end is in the type-2 state, then
type-2 monomers are added with forward and reverse
rates k+2 m0 and k
−
2 , respectively. Thus, polymers ex-
hibit one of two distinct growth modes, type-1 and type-
2, corresponding to the conformation of the monomer at
the active end and the resulting mechanism of elonga-
tion. Growth mode switching occurs when the monomer
at the active end converts, causing the emergence of an
elongating type-2 phase. Experimental results typically
support k+2 ≫ k
+
1 [4, 41], meaning that the switching
rate determines the lifetime of intermediates with a high
type-1 structure content, as well as the observed macro-
scopic kinetics of nucleated polymerization.
B. Characteristic timescales
Before deriving master equations to predict the macro-
scopic kinetics of nucleated polymerization, it is informa-
tive to consider the key conformational transitions that a
nascent polymer undergoes, and the timescales on which
they occur (Fig. 2). There are three key events that lead
to emergence of a type-2 growth mode: (i) initiation of
the polymer at a time t0, with all constituent monomers
initially in the type-1 state; (ii) non-autocatalytic con-
version of the first polymerized monomer at time tc >
t0, causing the formerly ‘pure’ intermediate to become
a mixed intermediate; and (iii) growth mode switch-
ing at time ts ≥ tc, which coincides with conversion
of the monomer at the active end (Fig. 2(a)). If the
first monomer to convert is situated at the active end,
then ts = tc; otherwise, additional conversion events
are required for growth mode switching to occur, so
that ts > tc. If kp ≪ kc, these additional conversion
events will be primarily non-autocatalytic and uncorre-
lated with one another; if kp ≫ kc, conversion of the first
monomer will stimulate autocatalytic conversion of its
neighbours, causing the type-2 state to propagate from
its point of origin to the active end. We also identify
three important time intervals: (i) the lifetime of a pure
intermediate, τc = tc − t0; (ii) the propagation time
τp = ts − tc, which is the time for a mixed intermedi-
ate to adopt a type-2 growth mode; and (iii) the total
switching time τs = ts − t0 = τc + τp, which is the total
time taken for an intermediate to acquire a type-2 growth
mode (Fig. 2(a)). In addition, we introduce a single do-
main wall propagation time τ ′p, which is distinct from τp
and will be discussed in greater detail in Sec. II. C.
We also consider two timescales related to the overall
self-assembly of populations of mature polymers: (i) the
characteristic self-assembly time τchar, and (ii) the inflec-
tion time τinf (Fig. 2(b)). Both are common experimen-
FIG. 2. Characteristic timescales of two-step biopolymer
nucleation. (a) Schematic showing an example of how the
length (j; black line) and AEM domain size (x; red line) of
a single polymer can change over time. The three key events
(Sec. II. B.) of initiation (t = t0), conversion of the first
monomer (t = tc), and growth mode switching (t = ts) are an-
notated with diagrams representing the change in conforma-
tional state of the polymer, with the following color scheme for
constituent monomers: green, unassembled; red, metastable
(type-1); blue, stable (type-2). (b) Schematic showing the
macroscopic self-assembly kinetics of a typical polymer popu-
lation (Sec. II. B.), and relevant characteristic times. Curves
represent the proportions of monomers which are unassembled
(m(t); green), or incorporated into polymers with a type-1
(M1(t); red) or type-2 (M2(t); blue) growth mode.
tal observables which are derived from phenomenological
analysis of biopolymer self-assembly curves, and can be
used to derive mechanistic conclusions [42, 43]. Specifi-
cally, the time-dependent mass of mature polymers fol-
lows a convex profile under circumstances where m0 is
approximately constant. If monomer depletion can oc-
cur, the self-assembly curve is sigmoidal and approaches
a constant limit due to exhaustion of the free monomer
[42] (Fig. 2(b)). For the purpose of this study, we identify
mature polymers as species with a type-2 growth mode,
and denote the effective concentration of monomer in-
corporated into such species as M2(t). The self-assembly
time τchar is the time required forM2(t) to reach an arbi-
trary, often small proportion of the initial free monomer
concentration m0, such that M2(τchar) = Cm0 and C is
a constant in the interval (0, 1) [42] (Fig. 2(b)). While
a number of different values of C are used, for small
C these different characteristic times typically produce
4similar scaling behaviors. The inflection time τinf is
the time at which M2(t) has its inflection point, such
that ∂2tM2(τinf) = 0 [43] (Fig. 2(b)). Because inflection
is a consequence of monomer depletion, τinf provides a
general timescale on which monomer depletion occurs.
Therefore, the assumption that m0 is approximately con-
stant implies that τs ≪ τinf, meaning thatM2(t) is locally
convex.
C. Growth mode switching as an absorbing
boundary problem
The ability of type-2 monomers to autocatalytically
induce conversion of their neighbors allows the type-
2 state to propagate to the active end from a distant
site of origin. Thus, the rate of growth mode switch-
ing depends not only on the conformational state of the
monomer at the active end, but also the length distribu-
tion of the domain of type-1 monomers adjacent to the
active end, which we term the ‘active end metastable’
(AEM) domain. When the size x of this domain becomes
zero, growth mode switching occurs (Fig. 2(a)). We are
primarily interested in far-from-equilibrium cases where
m0 ≫ k
−
2 /k
+
2 , so that growth mode switching has a neg-
ligible reverse process and can be treated as an absorb-
ing boundary problem. Initially, the polymer is formed
with all monomers in the type-1 state, so that x = j for
t0 ≤ t < tc. Following the first conversion event at t = tc,
the polymer acquires a mixed composition, so that x < j
for t ≥ tc. For t > tc, the AEM domain can grow due to
elongation at the active end (Fig. 1(c)), or contract due
to either dissociation of monomers from the active end
(Fig. 1(d)) or conversion of monomers within the AEM
domain (Fig. 1(e) & (f)). Growth mode switching occurs
when the AEM domain size hits an absorbing boundary
at x = 0, at the time ts.
The fact that both autocatalytic and non-autocatalytic
conversion events may occur during propagation leads to
a distinction between the total propagation time τp, and
the single domain wall propagation time τ ′p (Fig. 2(a)).
While autocatalytic conversion is restricted to the nearest
neighbors of type-2 monomers, non-autocatalytic conver-
sion is not. Thus, non-autocatalytic conversion of type-1
monomers within the AEM domain may cause a new do-
main wall to form, superseding the existing AEM domain
wall. While τp denotes the total time between the onset
of propagation and growth mode switching, τ ′p denotes
the time taken for a single domain wall to successfully
propagate to the active end, without being superseded.
Therefore, τ ′p only applies to propagation of the last AEM
domain wall to form before growth mode switching. If
the original domain wall successfully propagates to the
active end, then τ ′p = τp; otherwise, τ
′
p < τp.
D. General master equations
We consider the multivariate probability mass function
(PMF) pj,x(t; j0, t0), which gives the probability that a
polymer will have total length j, AEM domain size x, and
a type-1 growth mode at time t. The master equation for
pj,x(t) has the following form:
dpj,x(t)
dt
= δj,j0δx,j0δ(t− t0)
+ kc
j∑
y=x+1
pj,y(t)− kcxpj,x(t)
+ kp[θ(j-x-2)pj,x+1(t)− θ(j-x-1)pj,x(t)]
+ k+1 m0[pj−1,x−1(t)− pj,x(t)]
+ k−1 [pj+1,x+1(t)− pj,x(t)],
(1)
where δj,j0 and δ(t − t0) are the Kronecker and Dirac
deltas, respectively, and θ(z) is a step function such that
θ(z) = 1 if z ≥ 0 and θ(z) = 0 if z < 0. As with previ-
ous models [43–45], j0 is taken to be a minimum polymer
length below which rapid disassembly almost always oc-
curs; therefore, an absorbing boundary exists such that
pj0−1,x(t) = 0. In addition, to account for irreversible
growth mode switching, we impose the absorbing bound-
ary condition pj,0(t) = 0. While the first term in Eq. (1)
accounts for initiation at t = t0, the terms proportional
to kc, kp, k
+
1 m0, and k
−
1 account for non-autocatalytic
conversion, autocatalytic conversion, elongation, and dis-
sociation, respectively.
The terms accounting for non-autocatalytic conversion
introduce a jump process to Eq. (1), which complicates
efforts to satisfy the boundary conditions. Nonetheless,
analytical solutions can be obtained in specific cases. In
the case where x = j, corresponding to the length distri-
bution of intermediates with a purely type-1 composition,
the summation disappears and the problem becomes sig-
nificantly more tractable. We use this special case to
obtain 〈τc〉 in Sec. III. B. For mixed intermediates, the
time-dependence of AEM domain size can be solved by
summing over the polymer length. Let φx(t;xc, tc) rep-
resent the probability that a mixed intermediate has an
AEM domain of size x and a type-1 growth mode at time
t, given the boundary condition that x = xc when t = tc.
We can determine φx(t) by summing pj,x(t) over j:
φx(t) =
∞∑
j=j0∨x+1
pj,x(t), (2)
where j0 ∨ x + 1 denotes the maximum of j0 and x + 1.
The corresponding master equation is as follows:
dφx(t)
dt
= δx,xcδ(t− tc) + kc
∞∑
y=x+1
φy(t)− kcxφx(t)
+ k+1 m0[φx−1(t)− φx(t)]
+ (k−1 + kp)[φx+1(t)− φx(t)].
(3)
5As with related theories [42–44], we consider the case
where k−1 is small, allowing losses due to destabilization
of polymers with length j < j0 to be neglected. The ab-
sorbing boundary at x = 0 corresponds to growth mode
switching, and is retained. Eq. (3) is the discrete analog
of a jump-diffusion equation:
∂φ(x, t)
∂t
= δ(x− xc)δ(t− tc) + kc
∫ ∞
x
φ(y, t)dy
−
(
kcx+ µ
∂
∂x
−D
∂2
∂x2
)
φ(x, t),
(4)
where µ = k+1 m0−k
−
1 −kp and D = (k
+
1 m0+k
−
1 +kp)/2
are the drift and diffusion coefficients for AEM domain
size, with D ≥ 0 and −2D ≤ µ ≤ 2D. Because Eq. (3)
can be written in an equivalent form to Eq. (4), µ and
D are also informative in a discrete context. We define
an effective Pe´clet number xc|µ|/D for propagation of
the type-2 state to the active end. Propagation is pri-
marily diffusive when xc|µ|/D < 1, and advective when
xc|µ|/D > 1. In the advective case, the AEM domain
tends to contract if µ < 0, and expand if µ > 0. Thus,
µ is the expected rate of AEM domain expansion due to
the competing effects of type-1 growth and type-2 prop-
agation, and this competition provides the basis of the
critical behavior we observe in this paper.
III. CRITICAL PHENOMENA IN GROWTH
MODE SWITCHING
In this section, we investigate how the competing ef-
fects of propagation and elongation on AEM domain size
alter the lifetime of intermediates. Using a combina-
tion of stochastic simulations and analytical theory, we
uncover the existence of a nonequilibrium critical point
resulting from transcritical bifurcation of an order pa-
rameter Pe around the point µ = 0. This critical point
shares many common features with equilibrium second-
order phase transitions, including a jump in ∂µPe, critical
slowing, and diverging susceptibility to autocatalytic ef-
fects. These effects will be shown in the following section
to significantly affect the macroscopic kinetics of two-step
biopolymer self-assembly.
A. Existence of a nonequilibrium critical point
To evaluate how the competing effects of propagation
and elongation on AEM domain size alter the lifetime
of intermediates, we calculate the mean switching time
〈τs〉. For this purpose, we use a rejection-free kinetic
Monte Carlo (rfKMC; see Supplemental Material at [31])
algorithm to determine hitting times at the boundary
x = 0 in Eq. (1). The rfKMC algorithm converges to the
exact solution for the dynamics as the number of poly-
mers N → ∞ [46–48], and its application to biochemi-
cal problems including biopolymer self-assembly is well-
established [47, 49, 50]. In this case, the rfKMC algo-
rithm is preferable to deterministic methods as it samples
broad polymer size distributions more efficiently. For the
purpose of the simulations, we set k−1 = 0 so that there
is a single absorbing boundary, although our subsequent
mathematical analysis (Sec. III. C. & D.; [31]) is more
generally applicable to small, non-zero k−1 . In addition,
while we have carried out simulations for diverse j0, the
results are qualitatively similar in all cases [31]; therefore,
we focus on the j0 = 2 case as a representative example.
To explore the system’s limiting behavior in a 2D space,
it is convenient to normalize both the timescales and rate
constants with respect to kc. Therefore, we use relative
time kct and sample points in (kp/kc, k
+
1 m0/kc) space by
varying a pair of bounded, mechanistically significant pa-
rameters, µ/D and ζ = kp/(kc + kp). While µ/D defines
the tendency for expansion or contraction of the AEM
domain (Sec. II. D.), ζ is the proportion of the conver-
sion rate adjacent to a domain wall which is attributable
to autocatalytic effects. Thus, ζ provides a measure of
the importance of autocatalysis in conformational con-
version of the assembled monomers.
In Fig. 3(a), we show how the normalized mean growth
mode switching time kc〈τs〉 varies as a function of the
model parameters (µ/D, ζ). We use these data to plot
a nonequilibrium phase diagram, which we divide into
three different dynamical regimes ([31]; Fig. 3(c)): (A)
random, (B) cooperative, and (C) competitive. In the
random switching regime, elongation and autocatalysis
do not occur, so switching depends entirely on non-
autocatalytic conversion of the monomer at the active
end. In the cooperative regime (ζ → 1 when µ/D / 0)
(Fig. 3), autocatalytic conversion events allow the type-2
state to spread from a distant site of origin to the ac-
tive end. Thus, non-autocatalytic conversion events oc-
curring anywhere in the intermediate can indirectly lead
to growth mode switching, causing the instantaneous
switching rate to approach kcj. This means that mass
accumulation and autocatalytic conversion cooperate to
bring about a change in growth mode. In the compet-
itive regime, which arises for µ/D ' 0, the effects of
elongation on AEM domain size outweigh those of au-
tocatalytic conversion. Therefore, the AEM domain un-
dergoes net expansion, which inhibits propagation of the
type-2 state to the active end. This causes an increase
in kc〈τs〉, allowing accumulation of large, metastable in-
termediates with a mixed composition. In this regime,
mass accumulation and autocatalytic conversion can be
said to compete with one another. Although regimes A-
C are continuous with one another, we observe a singular
point at (µ/D, ζ) = (0, 1), where the second derivative of
〈τs〉 with respect to µ/D diverges in a manner resembling
a second-order phase transition (Fig. 3(a) & (b), 5(a)).
6FIG. 3. Two-step biopolymer nucleation exhibits distinct dynamical regimes. (a) Nonequilibrium phase diagram superimposed
on a heat map of mean growth mode switching time kc〈τs〉 (color scale). The solid and dashed lines are contours which separate
three dynamical regimes (A, random switching; B, cooperative; C, competitive). At the critical point (CP), ∂〈τs〉/∂(µ/D)
undergoes a jump. (b) A close-up of the heat map of kc〈τs〉 at high ζ values (0.95 ≤ ζ < 1.0). Varying µ/D or ζ close to the
critical point causes a rapid change in the switching time. (c) Schematics of regimes A-C, with color representing monomer
conformation: green, unassembled; red, metastable (type-1); blue, stable (type-2).
B. Lifetime of pure intermediates
The switching time 〈τs〉 must reflect a similar criti-
cal point in the lifetime of pure intermediates 〈τc〉, or
the propagation time of mixed intermediates 〈τp〉, since
〈τs〉 = 〈τc〉 + 〈τp〉. The fact that the critical point oc-
curs on the µ = 0 line, along which the competing effects
of autocatalytic conversion and elongation on AEM do-
main size are balanced, indicates that an effect on prop-
agation is responsible for the observed criticality. To
ascertain whether 〈τc〉 also plays a role in the critical
point, we solve Eq. (1) in the case x = j to obtain
a moment-generating function (MGF) for τc. As our
simulations were carried out in the k−1 = 0 case, we
apply the same condition when determining 〈τc〉. The
MGF of the first-conversion time is given by 〈e−sτc〉 =
1 − s
∑
pˆj,j(s), where pˆj,j(s) =
∫∞
t0
pj,j(t)e
−s(t−t0)dt is
the Laplace transform of pj,j(t). By taking the Laplace
transform of Eq. (1) in the case x = j and rearranging,
we obtain the following result [31]:
〈e−sτc〉 = 1−
s
kc
e
k
+
1
m0
kc
(k+1 m0
kc
)−( s+k+1 m0
kc
+j0
)
× γ
(s+ k+1 m0
kc
+ j0,
k+1 m0
kc
)
,
(5)
where γ is a lower incomplete gamma function. Thus,
〈τc〉 =
1
kc
e
k
+
1
m0
kc
(k+1 m0
kc
)−( k+1 m0
kc
+j0
)
× γ
(k+1 m0
kc
+ j0,
k+1 m0
kc
)
.
(6)
Eq. (6) decreases monotonically with k+1 m0/kc, and has
the limits 〈τc〉 → (kcj0)
−1 as k+1 m0/kc → 0, and 〈τc〉 → 0
as k+1 m0/kc → ∞. This behavior reflects the fact that
elongation increases the number of monomers within the
polymer which can non-autocatalytically convert, reduc-
ing the time until the first monomer converts. Thus,
if growth does not occur (k+1 m0/kc → 0), then the to-
tal conversion rate is simply kcj0. Conversely, if growth
is rapid, then the length goes to infinity and the time
until the first conversion event becomes negligible. Im-
portantly, Eq. (6) does not predict any form of critical-
ity, and the fact that it does not depend on kc means
that it cannot be expressed as a function of µ/D and ζ
alone. This prediction is confirmed by analysis of kc〈τc〉
values from our rfKMC trajectories, which we present in
Fig. 4(a). Given that k+1 m0/kc = [ζ(2+ξ)]/[(1−ζ)(2−ξ)],
the phase behavior of kc〈τc〉 in Fig. 4(a) is accounted for
by Eq. (6) alone, with no critical point. Thus, changes in
〈τp〉 rather than 〈τc〉 must be responsible for the observed
criticality.
7FIG. 4. The critical point in 〈τs〉 = 〈τc〉+ 〈τp〉 is caused by a similar critical point in 〈τp〉, but not 〈τc〉. (a) Heat map of kc〈τc〉,
the normalized mean lifetime of pure intermediates. The phase behavior is described by Eq. (6), and does not exhibit a critical
point at (µ/D, ζ) = (0, 1). (b) Heat map of kc〈τp〉, the normalized mean time for mixed intermediates to undergo growth mode
switching. Mixed intermediates are kinetically unstable (kc〈τp〉 = 0) along the line between (µ/D, ζ) = (−2, 1) and (0, 1), and
it follows that ∂〈τp〉/∂(µ/D) = 0 along this line as well. A second-order critical point (CP) occurs at (µ/D, ζ) = (0, 1), where
∂〈τp〉/∂(µ/D) jumps to a non-zero value.
C. Nature of the critical point
The critical point in 〈τs〉 must be caused by an abrupt
change in the manner in which the type-2 state propa-
gates to the active end. This deduction is supported by
analysis of kc〈τp〉 values from our rfKMC trajectories,
which we present in Fig. 4(b). While kc〈τc〉 is unaffected
by the critical point, kc〈τp〉 exhibits second-order critical
behavior similar to kc〈τs〉. Specifically, mixed interme-
diates are kinetically unstable (kc〈τp〉 = 0) along a line
from (µ/D, ζ) = (−2, 1) to (0, 1), corresponding to the
idealized case in the autocatalytic limit where propaga-
tion of the AEM domain wall to the active end is instan-
taneous. Because the value of kc〈τp〉 is constant along
this line, it follows that ∂〈τp〉/∂(µ/D) = 0 along this line
as well. At the critical point at (µ/D, ζ) = (0, 1), we
observe a jump in ∂〈τp〉/∂(µ/D) = 0, allowing kc〈τp〉 to
take nonzero values to the right of this point. To un-
derstand this result, let us consider the propagation of
a single AEM domain wall from its site of origin to the
active end. For this purpose, we solve Eq. (3) in the
case where kcx ≪ kp, so that the terms proportional to
kc become negligible. This describes the propagation of
a single domain wall when the probability of additional
non-autocatalytic conversion events is negligible (ζ → 1),
and x remains finite. We obtain φx(t;xc, tc) using lattice
Fourier transforms and the image method (see Supple-
mental Material at [31]):
φx(t) = e
−2D(t−tc)
(2D + µ
2D − µ
) x−xc
2
×
{
I|x−xc|[ν(t− tc)]− I|x+xc|[ν(t− tc)]
}
,
(7)
for x ≥ 0 and t ≥ tc, where Ix(t) is a modified Bessel
function of the first kind and ν =
√
4D2 − µ2. The
switching rate, which is equal to the hitting rate at
the boundary x = 0, is given by h(t;xc, tc) = (k
−
1 +
kp)φ1(t;xc, tc). We define an escape probability Pe(xc) =
limt→∞
∑
x φx(t;xc, tc), which is the probability that a
given AEM domain wall does not reach the active end
as t → ∞. In the ζ → 1 limit, this can only oc-
cur if x goes to infinity. In this case, additional non-
autocatalytic conversion events become non-negligible,
allowing propagation to be interrupted by formation of a
new domain wall closer to the active end. Thus, Pe(xc)
is the probability that the AEM domain does not dis-
appear without additional non-autocatalytic conversion
events occurring. From final value theorem, we find that
Pe(xc) = 1 − lims→0+ hˆ(s;xc). The Laplace transform
hˆ(s;xc) =
∫∞
tc
h(t;xc, tc) exp[−s(t− tc)]dt has the follow-
ing form [31]:
hˆ(s;xc) =
(s+ 2D − r±
2D + µ
)xc
, (8)
where r± = ±
√
s2 + 4Ds+ µ2. As shown in Fig. 5(b),
Eq. (8) delineates a parabola-like curve, which opens to
the right and whose upper (r−, unphysical) and lower
(r+, physical) branches meet at the point (s
∗, hˆ∗), where
s∗ = ν − 2D ≤ 0. When µ 6= 0, both branches intercept
the hˆ axis; when µ = 0, (s∗, hˆ∗) touches the hˆ axis and the
branches exchange intercepts, causing an abrupt change
in ∂µPe(xc):
Pe(xc) =
{
0, µ ≤ 0,
1−
(
2D−µ
2D+µ
)xc
, µ > 0.
(9)
In the ζ → 1 limit, autocatalytic conversion and
growth occur on much faster timescales than non-
autocatalytic conversion. Therefore, the mean switch-
ing time is asymptotically kc〈τs〉 ∼ limj→∞
{∑j−1
xc=0
[1−
8Pe(xc)]
}−1
= Pe(1) [31]. Thus, Eq. (9) explains the
critical point in kc〈τs〉, and the agreement between our
calculated scaling law and the simulated result is shown
in Fig. 5(a). The emergence of the critical point in the
ζ → 1 limit (Fig. 5(a)) is remarkably similar to the be-
havior of the 2D Ising model in the case of vanishing
magnetic field H [35]. Therefore, we propose that the
appearance of nonzero Pe(xc) for µ > 0 represents a
second-order phase transition, where Pe(xc) is an order
parameter and (µ, ζ) play an analogous role to (T,H) in
the Ising model. This transition is associated with the
emergence of a regime where mixed intermediates have
a finite lifetime, and their continued formation allows a
nonequilibrium steady-state population to persist.
D. Diverging propagation times and susceptibility
at the critical point
As further evidence for this critical point, we observe
that the moments of the propagation time diverge when
(µ/D, ζ) = (0, 1) (Fig. 5(c)). As discussed in Sec. II. C.,
τ ′p is the time taken for a single domain wall to success-
fully propagate to the active end, without being inter-
rupted by formation of a new domain wall closer to the
end (Fig. 2(a)). In the ζ → 1 limit, the nth-order moment
is given by 〈(τ ′p)
n〉 = (−1)n lims→0+(∂
n
s hˆ)/hˆ. The upper
and lower branches of hˆ meet at s∗ = 0 when µ = 0,
so the derivatives ∂ns hˆ diverge and the moments behave
correspondingly. More generally,
lim
ζ→1
〈τ ′p〉 =
xc
|µ|
, (10a)
lim
ζ→1
Var(τ ′p) =
2xcD
|µ|3
, (10b)
which strongly resembles the diverging magnetic suscep-
tibility χH = ∂HM near the Curie point. Because τ
′
p
is the time interval in which non-autocatalytic conver-
sion events can interrupt propagation, a connection to a
susceptibility of the form χζ ∝ ∂ζPe is highly intuitive.
To test this connection, we determine analytic bounds
for the susceptibility in the ζ → 1 limit. We define the
susceptibility as χζ = −∂ζPe = kp∂kcPe, where the sign
of our definition ensures a positive value, but does not
affect the presence or absence of a divergence. This is
essentially the effect of ζ on the probability that prop-
agation will be interrupted by a non-autocatalytic con-
version event in the AEM domain. By differentiating Eq.
(3) with respect to kc, we obtain a master equation which
can be used to determine ∂kcφ1(t, kc;xc, tc) [31]. In turn,
this can be used to assess the impact of kc on the hitting
rate and Pe. We solve this master equation to obtain
upper and lower bounds for ∂kcφ1(t, kc;xc, tc):
χζ = C(µ,D, xc)
kp(1− Pe)
2
〈τ ′p〉, (11a)
1 ≤ C(µ,D, xc) ≤ xc
(
2D
|µ|
)
+
(
2D
|µ|
)2
. (11b)
Thus, there is a divergence in χζ at the critical point
which has a scaling law between |µ|−1 and |µ|−3 and is
closely related to the divergence of 〈τ ′p〉 and Var(τ
′
p).
E. Relationship to a transcritical bifurcation
The exchange of intercepts by the branches of hˆ(s;xc)
closely resembles a transcritical bifurcation (Fig. 5(b)),
raising the question of whether Pe(xc) can be written as a
fixed point of the corresponding normal form. We begin
by noting that the escape probability can be expressed
as a limit Pe(xc) = limt→∞ Φ(t;xc, tc) of the probability
Φ(t;xc, tc) =
∑
x φx(t;xc, tc) that the AEM domain wall
has not yet propagated to the active end, under condi-
tions where kc is sufficiently small that additional non-
autocatalytic conversion events are negligible. Because
Pe(xc) = 1 − [1 − Pe(1)]
xc , a bifurcation in Pe(1) must
cause a similar behavior in Pe(xc) [31]; therefore, we fo-
cus on the case where xc = 1. Using the conservation
law ∂tΦ(t;xc, tc) = δ(t − t0) − h(t;xc, tc), we re-express
Eq. (8) in the form:
s2Φˆ(s; 1)− s = µsΦˆ(s; 1)− k+1 m0s
2Φˆ(s; 1)2. (12)
Either by applying final value theorem and the power
rule of limits [51] to Eq. (12), or by taking the inverse
Laplace transform and evaluating the convolution that
corresponds to the Φˆ(s; 1)2 term, it is possible to obtain
the following result in the t→∞ limit [31]:
dΦ(t; 1, tc)
dt
≈ µΦ(t; 1, tc)− k
+
1 m0Φ(t; 1, tc)
2. (13)
This is the normal form of a transcritical bifurcation. The
physical and non-physical branches of Eq. (8) correspond
to the regions of Eq. (13) where ∂tΦ(t; 1, tc) decreases
or increases with Φ(t; 1, tc), respectively, and the ex-
change of intercepts between these branches corresponds
to an exchange of stability between the fixed points of
Φ(t; 1, tc). Solutions to Eq. (13) provide insights into the
diverging mean and variance of τ ′p at the critical point,
as the hitting rate can be derived from Φ(t; 1, tc) accord-
ing to the formula h(t; 1, xc) = −∂tΦ(t; 1, tc) [31]. When
µ 6= 0, the solution is a logistic function, so that the
hitting rate is exponentially bounded. However, when
µ = 0, the solution is ∼ (k+1 m0t)
−1, meaning that the
hitting time distribution becomes heavy-tailed and its
moments diverge. This is an example of critical slow-
ing, and is caused by the disappearance of the linear
term in ∂tΦ(t; 1, tc). In equilibrium systems, a relation-
ship between critical slowing and diverging susceptibility
can be established by considering the Landau potential
V (Φ), which satisfies the law ∂tΦ = −∂ΦV (Φ). Both
the relaxation time following a small variation, and the
susceptibility of Φ to a linearly coupled external field,
are inversely proportional to ∂2ΦV (Φ). At the critical
point, disappearance of the linear term in ∂tΦ means that
∂2ΦV (Φ) = 0, so that both the relaxation time and suscep-
tibility diverge. In our system, the connection between
9FIG. 5. A continuous phase transition arises in the limit ζ = kp/(kc + kp)→ 1. (a) Dependence of kc〈τs〉 on µ/D for varying
kp. Color scale: solid black, kp = 0; gray, kp = kc; purple, kp = 10kc; blue, kp = 10
2kc; green, kp = 10
3kc; amber, kp = 10
4kc;
red kp = 10
5kc; dashed black, asymptotic scaling law from Eq. (9), showing emergence of a critical point at µ/D = 0. (b)
Origin of the criticality, showing an exchange of intercepts by the physical and non-physical branches of hˆ(s;xc) in the ζ → 1
limit. Color scale: blue, µ = −D; black, µ = 0; red, µ = D. (c) Divergence of the mean (kp〈τ
′
p〉/xc; dashed) and variance
(k2pVar(τ
′
p)/xc; solid) of the single domain wall propagation time around the critical point in the ζ → 1 limit, normalized with
respect to kp and xc.
critical slowing and the susceptibility is more direct, as
the mean propagation time defines a lower bound for the
susceptibility. Nonetheless, the principle is similar, in
that the exchange of stability by the fixed points causes
disappearance of the linear term in Eq. (13), allowing
the susceptibility to another parameter to diverge.
It is possible to obtain an effective potential of the
form V (Φ) = −µΦ2/2 + k+1 m0Φ
3/3 by integrating Eq.
(13) with respect to Φ. However, this result must be in-
terpreted with caution. Thermodynamic equilibrium re-
lies on microscopic reversibility, which does not exist for
our parameter Φ(t; 1, tc). Due to the irreversible nature
of growth mode switching, Φ(t; 1, tc) can only decrease;
thus, the regions of Eq. (13) for which ∂tΦ(t; 1, tc) > 0
are non-physical, and correspond to the parts of hˆ(s; 1)
situated at s < 0 (Fig. 5(b)). Instead, we propose that
the shared feature between our critical point and those
observed in equilibrium systems is the presence of a bifur-
cation. While our bifurcation is the result of irreversible
dynamics, bifurcations observed in equilibrium systems
are caused by large numbers of microscopically reversible
processes. Nonetheless, because these processes result in
similar dynamical laws, our model has many features in
common with equilibrium phase transitions.
IV. EFFECTS OF CRITICALITY ON THE
MACROSCOPIC SELF-ASSEMBLY KINETICS
Autocatalytic biopolymer systems with high ζ will ex-
hibit a nonlinear response to µ near the critical point.
In this section, we evaluate the effects of this critical-
ity on the macroscopic self-assembly kinetics. We begin
by estimating likely ζ values based on typical biological
free energy scales. We find that stabilization of confor-
mational transition states by even modest free energy
differences (< 10kBT ) can result in highly autocatalytic
conformational conversion. Thus, different biopolymers
are expected to exhibit the full spectrum of autocatalytic
behaviors predicted by our model. In systems with high
ζ, the critical point has a profound effect on the macro-
scopic kinetics, inducing rapid changes in the size and
abundance of steady-state populations of intermediates,
and the concentration-dependent scaling behavior of the
formation of mature polymers. These effects are not
predicted by existing local equilibrium models [52–54],
and indicate that nonequilibrium criticality may explain
widespread experimental phenomena [55, 56] which one-
step nucleation models have not been able to address.
A. Estimation of ζ from Kramers theory
Critical behavior arises in the autocatalytic (ζ → 1)
limit (Fig. 3(b)). Although kc is non-zero and kp is fi-
nite, meaning that a value of ζ = 1 is not strictly pos-
sible, ζ can be asymptotically close to this limit. Real-
istic ζ values can be estimated from reaction rate the-
ory. Let us consider the conversion rate of a single type-
1 monomer in the AEM domain, situated n monomers
from the active end. We represent the conformation of
the monomer with a single continuous degree of freedom,
qn; however, we note that our analysis can be general-
ized to cases where monomers have additional slow de-
grees of freedom without changing the conclusions. The
free energy G(qn; qn−1, qn+1) of a polymerized monomer
depends on its own conformation qn, and a term ac-
counting for interactions with the adjacent monomers
qn−1 and qn+1. The monomer at position n has free
energy minima corresponding to the type-1 and type-
2 states, which are situated at qn = p1 and qn = p2.
These minima are separated by a barrier at qn = p
‡,
which corresponds to a conformational transition state.
The fact that conversion has a negligible reverse pro-
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cess entails that G(p1; qn−1, qn+1) ≫ G(p2; qn−1, qn+1),
and the effectively two-state nature of our model en-
tails that G′′(p1; qn−1, qn+1) and G
′′(p2; qn−1, qn+1) are
both large. Therefore, the conformation qn′ of all non-
converting monomers n′ 6= n is assumed to be close to
p1 or p2. Monomers situated closer to the active end
(n′ < n) are part of the AEM domain, and must be in
the type-1 state (qn′ ≈ p1); monomers situated further
from the active end (n′ > n) may be in either the type-
1 or type-2 state (qn′ ≈ p1 or qn′ ≈ p2). Although it
is possible to write a Langer equation [57, 58] for the
conversion rate which accounts for continuous conforma-
tional variation in the monomers at positions n′ 6= n,
the results are hard to interpret. The main reason for
this is that such a model predicts dynamics based on the
j-dimensional free energy function
∑
nG(qn; qn−1, qj+1),
which has 2j−1 relevant saddle points. Instead, we sim-
plify the analysis by neglecting variation in qn′ about the
points p1 or p2. We write the free energy of the monomer
at position n as a pair of functions corresponding to the
two possible conformations of the monomer at position
(n+ 1):
G1(qn) = G(qn; p1, p1), (14a)
G2(qn) = G(qn; p1, p2). (14b)
The monomer conformation exhibits ovderdamped
Langevin dynamics, so that the corresponding conforma-
tional probability density functions ρ1(qn, t) and ρ2(qn, t)
satisfy the following Fokker-Planck equation:
∂ρi
∂t
=
∂
∂qn
Di
[
∂ρi
∂qn
+ βρi
dGi
dqn
]
(15)
where i = 1, 2 is the conformation of the monomer at
position (n + 1), β = 1/kBT , and Di(qn) is the confor-
mational diffusion coefficient. The conversion rate can be
estimated from Gi(qn) and Di(qn) using Kramers theory
[58, 59]. The non-autocatalytic conversion rate is given
by the passage rate at the barrier (qn, qn+1) = (p
‡, p1):
kc =
βD1(p
‡)
2pi
[
G′′1(p1)|G
′′
1(p
‡)|
]1/2
e−β∆G
‡
1 , (16)
where ∆G‡1 = G1(p
‡) − G1(p1). Similarly, the autocat-
alytic conversion rate is given by the passage rate at the
saddle point (qn, qn+1) = (p
‡, p2):
kc + kp =
βD2(p
‡)
2pi
[
G′′2(p1)|G
′′
2(p
‡)|
]1/2
e−β∆G
‡
2 , (17)
where ∆G‡2 = G2(p
‡)−G2(p1). Therefore, the definition
ζ = kp/(kc + kp) gives the result:
ζ = 1−
D1(p
‡)
[
G′′1(p1)|G
′′
1(p
‡)|
]1/2
D2(p‡)
[
G′′2(p1)|G
′′
2(p
‡)|
]1/2 e−β∆∆G‡ , (18)
where ∆∆G‡ = ∆G‡1 − ∆G
‡
2 is the reduction in the
free energy barrier of conversion due to autocatalytic ef-
fects. It is not immediately obvious whether the pre-
exponential ratio would have a value greater or less than
1. While ordering of the (n + 1) monomer might be ex-
pected to reduce conformational diffusion, the simulta-
neous loss of complementarity between the monomers’
structures might exert the opposite effect. The effects
on G′′(p1) and G
′′(p‡) are also hard to gauge, and may
be biopolymer-specific. In the absence of further infor-
mation, we set the value of the pre-exponential ratio
to 1, so that ζ = 1 − exp (−β∆∆G‡), and we exam-
ine the relationship between ζ and ∆∆G‡. Eq. (18)
predicts that even high ζ values will be associated with
relatively modest free energy differences; for example,
ζ = 0.999 ⇔ kp ≈ 10
3kc implies ∆∆G
‡ = 6.9 kBT ,
which is well within the range of typical biological free
energy scales at T = 310K. For comparison, formation
of a single hydrogen bond in protein has a free energy
change of ∼ 2 kBT [60, 61], and estimated free energy
barriers for protein folding are mostly in the 2− 20 kBT
range [62], accounting for the effects of large numbers of
competing, non-additive interactions. In addition, a re-
cent experimental study of biopolymer nucleation by the
Aβ peptide indicated that autocatalytic interactions be-
tween polymers reduce the nucleation free energy barrier
by ∆∆G‡ = 19 kBT [63]. Although this form of au-
tocatalysis is different from the form that we consider
here, as it depends on interactions between polymers
rather than within a polymer, the two processes may
share a common physical basis. It is interesting to note
that an equivalent ∆∆G‡ value in our model would give
ζ ≈ 1− 10−8 ⇔ kp ≈ 10
8kc, resulting in highly autocat-
alytic behavior. Thus, we believe that values of ζ close
to the ζ = 1 limit are highly plausible, meaning that
biopolymer systems will frequently exhibit high levels of
autocatalysis and resulting critical behavior.
B. Nonlinear response to perturbations in the
autocatalytic limit
We now investigate the response of the macroscopic
self-assembly kinetics to variations in µ/D, when ζ is
high. To do so, we calculate the time-evolution of the
principal moments of the polymer length distribution.
Let fi,j(t) represent the concentration of polymers with
growth mode i = 1, 2 and length j at time t. In parallel
with the notation used by [43, 44], we define the following
principal moments:
Pi(t) =
∞∑
j=j0
fi,j(t), (19)
Mi(t) =
∞∑
j=j0
jfi,j(t). (20)
The zeroth-order moment Pi(t) is the total concentration
of polymers with growth mode i, and acts as an effective
normalization constant for fi,j(t). The first-order mo-
ment Mi(t) is the effective concentration of monomers
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incorporated into polymers with growth mode i, or the
‘polymer mass-concentration’. The mean polymer length
Li(t) can be obtained by the normalization:
Li(t) =
Pi(t)
Mi(t)
. (21)
Let us begin by examining the effect of the critical point
onM1(t) and L1(t). The length distribution f1,j(t) of the
population of type-1 species contains contributions from
individual polymers initiated at all t0 < t. If nucleated
polymerization begins when t = 0, then
f1,j(t) = vn
j∑
x=1
∫ t
0
pj,x(t; t0)dt0 (22)
where vn = knm
j0
0 is the nucleation rate. Thus,
P1(t) = vn
∞∑
j=j0
j∑
x=1
∫ t
0
pj,x(t; t0)dt0, (23)
M1(t) = vn
∞∑
j=j0
j
j∑
x=1
∫ t
0
pj,x(t; t0)dt0. (24)
In Sec. III. A., we obtained numerical solutions for
pj,x(t; t0) using an rfKMC algorithm. We will now use
these solutions to predict M1(t) and L1(t), by applying
Eq. (23-24). As we are specifically interested in the
response of the system to varying µ/D at high ζ, we
will focus on cases where µ/D varies through the range
[−2, 2), while ζ is fixed at the value ζ = 0.999 ⇔ kp ≈
103kc. This value is associated with a comparatively
small ∆∆G‡, and so is physically very plausible (Sec.
IV. A.).
In Fig. 6, we present the effect of µ/D on the time-
evolution of αM1(t) and L1(t), where α = kc/vn is a
normalization constant facilitating the use of relative
time kct. The integral
∫∞
0
pj,x(t; t0) converges, allow-
ing both αM1(t) and L1(t) to approach steady-state
values αMss = α limt→∞M1(t) (Fig. 6(a) & (b)) and
Lss = limt→∞ L1(t) (Fig. 6(b)) in the t → ∞ limit.
These nonequilibrium steady states reflect the concen-
trations and size of intermediates likely to be observed
in physiological contexts, if the free monomer concentra-
tion and chemical environment are stable on timescales
≫ τsteady, where τsteady is the approximate timescale
taken to reach the steady state. In experimental contexts,
the pre-steady-state behavior is likely to dominate in the
self-assembly lag phase if τinf ≪ τsteady, and the steady-
state behavior is likely to dominate if τinf ≫ τsteady.
We will evaluate the effects of the critical point on both
the pre-steady-state kinetics and the steady-state kinet-
ics. The pre-steady-state kinetics appear linear when
plotted on double-logarithmic axes (Fig. 6(a)), indicat-
ing that they are described by a power law of the form
αM1(t) ∝ t
d. Power laws are often observed in biopoly-
mer self-assembly kinetics where t is small, and d can be
interpreted as the number of sequential processes con-
tributing to biopolymer mass accumulation; thus, nucle-
ation without polymerization gives d = 1, and nucleated
polymerization gives d = 2. To assess whether the pre-
steady-state kinetics are affected by the critical point,
we calculated d = ∂ lnM1(t)/∂ ln t|kct=0.01 for varying
µ/D (Fig. 6(b)). Although d increases with µ/D, reflect-
ing the increasing importance of polymerization in mass
accumulation, there is no clear response to the critical
point. This is unsurprising, given that the critical point
results from changes in growth mode switching, which is
negligible in the pre-steady-state.
In contrast, the steady-state kinetics are strongly af-
fected by the critical point. We begin by examining the
effect of the critical point on τsteady. For the purpose of
this analysis, we define τsteady such that αM1(τsteady) =
0.9αMss. As shown in Fig. 6(a), τsteady initially decreases
with increasing µ/D, as both elongation and propagation
cooperate to accelerate growth mode switching. How-
ever, this trend reverses close to the critical point, causing
a delay in the approach to the steady-state and allow-
ing greater accumulation of polymer mass. This delay
corresponds to the emergence of a population of large,
conformationally mixed intermediates. As a result, both
αMss and Lss exhibit a highly nonlinear response to µ/D
around the critical point (Fig. 6(a) & (b)). In physiolog-
ical and experimental contexts, this means that small
variations in the free monomer concentration or solvent
composition have the potential to induce large changes in
the populations of biopolymer nucleation intermediates.
In addition, the total rate of growth mode switching is
strongly dependent on the size and nature of the interme-
diate populations, so the increase in τsteady will strongly
affect the accumulation of mature polymers with a type-2
growth mode.
C. Low concentration-dependence is a dynamical
signature of a nonequilibrium critical point
As discussed in Sec. II. B., a common experimental
descriptor of the macroscopic self-assembly kinetics is
the characteristic time τchar at which M2(τchar) = Cm0,
where C is an arbitrary constant (Fig. 2(b)). The
concentration-dependence of τchar can be described using
a scaling exponent γ, which has the following definition:
γ = −
∂ ln τchar
∂ lnm0
. (25)
In cases where C is sufficiently small (0 < C / 0.5),
mechanistic conclusions can be drawn from the value of
γ [42]. For example, the Oosawa model predicts γ = nc/2
[33], where nc is the nucleation order, and the nucleation-
conversion-polymerization (NCP) model, which assumes
instantaneous growth mode switching, predicts γ = nc/3
[21]. To illustrate the impact of the abrupt change in
τsteady on the macroscopic self-assembly kinetics, we pre-
dict γ values based on our simulations. We begin by
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FIG. 6. Varying µ close to the critical point (kp = 10
3kc) results in a highly nonlinear response of the macroscopic kinetics.
(a) Time-evolution of the mass of species with a type-1 growth mode, αM1(t), for varying µ/D. Color scale: red, µ/D = −2;
orange, −1.9; yellow, −1.5; green, −1; cyan, −0.5; blue, 0 (starred, critical); indigo, 0.5; purple, 1; gray, 1.5. The dashed line
plots the (kct, αM1(t)) at which αM1(t) = 0.9αMss, for varying µ/D. (b, left axis) Effect of µ/D on the steady-state mass
(αMss; solid black) and length (Lss; dashed black) of species with a type-1 growth mode. (b, right axis) Effect of µ/D on the
scaling exponents d (red) and γ (blue). (c) Dependence of γ on µ/D, for varying ζ. Color scale: red, ζ = 0; amber, ζ = 0.9;
green, ζ = 0.99; blue, ζ = 0.999; purple, ζ = 0.9999; dark gray, ζ = 0.99999.
observing that:
df2,j(t)
dt
= vn(k
−
1 + kp)
∫ t
0
pj,1(t; t0)dt0
+ k+2 m0[f2,j−1(t)− f2,j(t)]
− k−2 [f2,j+1(t)− f2,j(t)].
(26)
Our rfKMC simulations were carried out in the k−1 → 0
limit, meaning that the following conservation principle
applies:
P2(t) = vnt− P1(t). (27)
To simplify our analysis, let us consider the case where
k+2 m0 ≫ Mss/τs, so that the predominant contribu-
tion to the type-2 polymer mass comes from elongation,
rather than conversion of intermediates. Therefore,
M2(t) ≈ k
+
2 m0
∫ t
0
P2(τ)dτ. (28)
In the pre-steady-state (t ≪ τsteady), P1(t) is approx-
imately linear, so both P2(t) and M2(t) will exhibit
higher-order scaling with time. In the steady-state (t≫
τsteady), P1(t) is approximately constant, meaning that
P2(t) and M2(t) will exhibit linear and quadratic scal-
ing with time, respectively. It is more convenient to
express concentrations in relative units than it is to
choose arbitrary values of the rate constants. There-
fore, we calculate α′M2(t) using Eq. (23, 27-28), where
α′ = (k+1 /kp)
j0+1(k2c/knk
+
2 ) is a normalization constant,
and set C = 0.01/α′. From the definition of µ and D, we
find that
∂ ln
(
µ
D
)
∂ lnm0
=
4−
(
µ
D
)2
4
(
µ
D
) . (29)
Thus, under circumstances where the rate constants are
kept fixed, variation in µ/D can be attributed to changes
in the free monomer concentration m0. This means that
we are able to determine γ by calculating τchar for vary-
ing, finely spaced µ/D values, estimating the logarithmic
derivative with respect to µ/D from the corresponding
finite difference equation, and then multiplying by the
right-hand side of Eq. (29). In Fig. 6(c), we present the
results obtained for various ζ. At low ζ, γ monotoni-
cally transitions between the limits limµ→−2 γ = 1 and
limµ→2 γ = 2/3, which agree with the predictions of [33]
and [21] discussed above. However, a minimum in γ ap-
pears at high ζ, which starts at the point µ/D = 2 and
moves towards µ/D = 0 as ζ → 1. This depression occurs
because µ/D scales withm0, so that increasingm0 causes
a reduction in growth mode switching, inhibiting fur-
ther acceleration of type-2 mass accumulation. In highly
autocatalytic systems (kp > 10
3kc), the effect is severe
enough to cause a temporary reversal in concentration-
dependence. As the minimum γ decreases, the drop in γ
becomes increasingly sharp about the point µ/D = 0.
Both the low concentration-dependence (γ < 0) and
sharp drop in γ predicted by our model are commonly ob-
served in experimental studies, but cannot be explained
by existing models [52–54]. Furthermore, while exist-
ing models invoke local equilibria to explain low γ [52–
54], our model predicts a low γ purely as a result of the
dynamics. We thus propose that a low concentration-
dependence in biopolymer self-assembly may represent
the dynamical signature of nonequilibrium critical point.
V. DISCUSSION
Biopolymer self-assembly is a fundamental mechanism
of biological organization, and plays a key role in dis-
ease. Experimental and computational studies have re-
vealed that monomers often populate metastable confor-
mational states during the process of self-assembling to
form a biopolymer [40, 64–66]. As a result, nucleation of
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a biopolymer often proceeds via one or more metastable
intermediates, whose constituent monomers are confor-
mationally distinct from those within the mature poly-
mer. In addition, monomers within the same interme-
diate often exhibit considerable conformational hetero-
geneity. This complexity has challenged our ability to
extract detailed mechanistic information at the molecu-
lar level. Current mathematical models either neglect the
conformational heterogeneity of the assembled monomers
entirely, or assume that monomers within the same inter-
mediate rapidly assume the same conformational state,
so that intermediates with a mixed composition are not
observed. However, mixed intermediates are commonly
observed in experiments and simulations, indicating that
mathematical models which neglect these dynamics are
only applicable under highly simplified experimental con-
ditions [64]. Moreover, this conformational diversity is
responsible for many of the most important biological be-
haviors of biopolymers [67–69]. One notable example is
the role of intermediates in the assembly of amyloid fibres
from protein monomers. The conformational heterogene-
ity of amyloid self-assembly intermediates allows them to
interact with a diverse range of other biomolecules [70].
This disrupts cellular function and is causative in the
majority of degenerative conditions of aging, including
Alzheimer’s and Parkinson’s diseases [16, 18, 71–74].
In this paper, we address this issue by introducing a
minimally complex process by which the self-assembled
monomers are able to exhibit conformational heterogene-
ity, and change conformation over time. This simple ad-
dition causes our model to exhibit rich, critical dynam-
ics. As a result, the macroscopic self-assembly kinet-
ics display features such as a highly nonlinear depen-
dence of steady-state intermediate populations on the
self-assembly conditions, and loss or even inversion of the
concentration-dependence of the self-assembly rate of the
stable phase. These phenomena are commonly observed
in experimental studies [55, 56], but are not explained by
existing models. Thus, for the first time, the initiation-
propagation (IP) model proposed here allows quantita-
tive predictions to be made regarding the concentration
of conformationally heterogeneous intermediates.
A. Competing dynamics in morphologically diverse
intermediates
While polymeric intermediates are commonly observed
in biopolymer self-assembly, a diverse range of other
intermediate morphologies are also observed, including
small prenucleation clusters with an apparently ran-
dom organization of constituent monomers [75, 76], large
spheroidal intermediates [52, 77, 78], and species possess-
ing fractal geometry which is evident at a macroscopic
scale [79]. In addition to applying to polymeric interme-
diates, we expect the conclusions of our study to gen-
eralize to these other diverse geometries. To make this
generalization, we note that propagation involves incor-
poration of monomers into a growing stable phase by
autocatalytic conversion of condensed monomers in the
intermediate phase. Thus, the dimensionality of propa-
gation is defined by that of the stable phase. In an n-
dimensional intermediate, propagation will manifest as
linear growth of the stable phase through the interme-
diate, with the growth mode switching when an auto-
catalytic end reaches the solvent. This form of prop-
agation is well-supported by experimental observations
of spheroidal intermediates [6, 14, 15], which are often
large enough to be observed by light microscopy tech-
niques. In these studies, the stable polymeric phase ap-
pears to originate within the intermediate by conforma-
tional rearrangement of a subset of the monomers, and
then emerge from the surface of the intermediate. When
the active end reaches the solvent, the dramatic change
in the physicochemical environment, and the availability
and conformational state of nearby monomers, would be
expected to induce a marked change in the growth behav-
ior of the polymeric phase analogous to the switch from
propagation (kc+ kp) to type-2 growth (k
+
2 m0) behavior
in our polymer model.
The fact that polymerization is likely to manifest as
linear growth-like behavior in multidimensional interme-
diates means that we expect IP models involving such
intermediates to reduce to pseudo-1D absorbing bound-
ary problems. A transition from a regime where Pe = 0
to one where Pe > 0 is a general feature of such problems
[80], so we expect similar transitions for diverse interme-
diate geometries. It is also important to note that our
critical point is conserved in the continuous limit of x, ie.
the case where the intermediate is so large as to behave
like a continuous phase, rather than a discrete collection
of monomers. In this limit, we obtain the classical results
for first-passage of Brownian motion with drift [81], and
a jump in ∂µPe(xc) occurs about the point µ = 0 [31].
Besides the discrete polymer example considered in this
paper, IP mechanisms with a number of other intermedi-
ate geometries are likely to be mathematically tractable.
For example, in the case of spherical intermediates with
a continuous-like composition, the problem considered in
Sec. II. can be recast as a continuous advection-diffusion
(Eq. (4)) along a 1D trajectory towards a spherical ab-
sorbing boundary. In the simplified case of radial propa-
gation, we have performed a quick calculation to estimate
the rate at which large spherical intermediates give rise
to a growing stable polymers [31]. While this rate is pro-
portional to the volume of the intermediates in the coop-
erative regime, it is proportional to their surface area in
the competitive regime. This behavior closely resembles
the way in which initiation sites for successful propaga-
tion events are restricted to the ends of polymeric in-
termediates in the competitive switching regime. Thus,
a more general principle may exist, in which the com-
petition between growth and propagation dynamics cre-
ates two distinct regimes. In one, a polymerizing stable
phase may originate from anywhere within the volume
of the intermediate; in the other, the sites where such
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a phase may originate are restricted to the boundary of
the intermediate. The fact that a critical point separat-
ing these regimes appears to be a widespread feature of
two-step biopolymer nucleation pathways underlines the
more general principle that the prerequisites for critical
behavior are relaxed in far-from-equilibrium systems.
In addition to being compatible with a wide range of in-
termediate morphologies, our IP mechanism also predicts
significant morphological diversity. The incorporation of
a single alternative monomer conformation means that
polymers of a given length may exhibit a large number
of different sequences of type-1 and type-2 monomers.
Because the conformation of a monomer affects its me-
chanical properties, we would expect these different se-
quences to result in diverse morphologies. In this study,
we have primarily focused on the mechanism of growth
mode switching, and have ignored aspects of the confor-
mational conversion dynamics which are not relevant to
this problem. However, in future studies it may be possi-
ble to rigorously predict changing polymer morphologies
by obtaining analytical solutions to describe the progres-
sive conversion of monomers throughout the polymer.
As an example of how polymer composition might af-
fect morphology, we observe that monomers in the type-1
and type-2 states are likely to exhibit differing degrees of
conformational ordering. It is most often assumed that
the intermediate is less ordered than the stable species, so
that conformational conversion can be regarded as an or-
dering transition. In this case, the conformational degen-
eracy of the type-1 state would be expected to result in
greater flexibility for type-1 domains. As the monomers
within a polymer converted to the type-2 state, we would
expect to see a progressive increase in the persistence
length lp. However, in cases where the persistence length
of the type-1 and type-2 monomers are markedly dif-
ferent, presence of a small number of type-1 monomers
would be expected to strongly affect the overall morphol-
ogy of the polymer. Thus, polymers with a small but sig-
nificant type-1 content might exhibit radically different
morphologies from mature polymers, as is often observed
experimentally [66, 82, 83].
It would also be possible to introduce further con-
formational diversity to our model, by introducing ad-
ditional metastable conformations for the polymerized
monomers. While analysis of such a model would not be
trivial, additional conformational freedom and the pres-
ence of other slow dynamics might be expected to yield
even richer behaviors than those presented here. How-
ever, it is useful to note that structural data from solid-
state nuclear magnetic resonance (NMR) studies sug-
gest that monomers within amyloid fibrils occupy a lim-
ited range of stable or metastable conformations [84, 85],
while high-resolution microscopy data have revealed a di-
verse range of morphologies [82, 86]. Therefore, even in
amyloid systems where the free monomer is often highly
conformationally degenerate, the range of accessible con-
formations seems to remain limited within the polymer.
Thus, a simple model in which polymerized monomers
occupy one of two conformations may be sufficient to ac-
count for much of the observed morphological diversity.
B. Explicit conversion dynamics are essential to a
general two-step biopolymer nucleation model
The inclusion of explicit conformational conversion dy-
namics also allows our IP model to exhibit a generality
not seen in other two-step nucleation models. Propa-
gation of the stable phase is not assumed to be instan-
taneous, and can occur on timescales similar to either
polymerization of the intermediate or non-autocatalytic
conversion (Fig. 2). As a result, the dynamical behavior
of our model depends on two key parameters, µ/D and ζ.
The first of these, µ/D, describes the competing effects of
propagation and polymerization on the time-dependence
of growth mode switching. When µ/D < 0, the stable
phase propagates through the intermediate faster than
the intermediate phase can polymerize, causing acceler-
ated switching. When µ/D > 0, polymerization is rapid
and reduces the likelihood of successful propagation. The
second parameter, ζ, compares the timescale for propa-
gation due to autocatalytic conversion with the timescale
for non-autocatalytic conversion. When ζ = 0, nearest-
neighbor interactions between monomers do not promote
conformational conversion, so that the rate of growth
mode switching is independent of the length of the poly-
mer. When ζ = 1, nearest-neighbor interactions strongly
promote conversion, so that the timescale for propagation
is much faster than that of non-autocatalytic conversion,
and the rate of growth mode switching is accelerated.
Existing models which neglect the conversion dynam-
ics are not able to consider the variation accounted for
by µ/D and ζ, and thus make various assumptions re-
garding the rate at which the new growth mode emerges.
While certain models [20, 22] have correctly supposed
a connection between intermediate size and the rate of
emergence of a growing stable phase (eg. kc〈τs〉 ≈ 1/j),
the lack of competing dynamics means they are restricted
to a limited range of points close to the top left (ζ → 1,
µ/D < 0) of our phase diagram (Fig. 3(a)). In contrast,
other models have assumed that there is no relationship
between intermediate size and the switching rate [19, 21]
(ie. kc〈τs〉 ∝ 1). Justifications for this behavior include
irrelevance of size due to the lack of a growth process, or a
scenario in which monomer conversion is highly coopera-
tive. While the former is plausible in specific cases where
growth of intermediates is slow, the latter is unlikely to
be widely observed, as intermediates are typically either
low-dimensional or have highly degenerate monomer in-
teractions. However, a sufficient level of cooperativity
may occur in exceptional cases where monomers within
intermediates exhibit a limited variety of interactions
with a large number of neighbors. In our model, length-
independence arises in two scenarios: when conversion
is entirely non-autocatalytic so that adjacent monomers
convert independently (ζ = 0); and when growth is suf-
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ficiently rapid that growth mode switching is inhibited
(µ/D → 2). Thus, the behavior assumed by [19, 21]
will be observed at points on our phase diagram corre-
sponding to these limits (Fig. 3(a)). It is important to
emphasize that we expect length-independence to be a
somewhat unusual phenomenon. Even stabilization of
the conformational transition state by a small free en-
ergy (∼ 1 kBT ) would result in a significant ζ value,
and in the vast majority of our phase space some level of
reduction in kc〈τs〉 is observed (Fig. 3(a)).
We have seen that existing models of two-step biopoly-
mer nucleation describe a limited range of possible sce-
narios, which are restricted to points close to three lines
(ζ → 1 given µ/D < 0; ζ = 0; and µ/D → 2) on the
limits of our phase diagram (Fig. 3(a)). As a result,
these models exhibit markedly different behaviors which
appear difficult to reconcile. By explicitly considering
the dynamics by which conversion of monomers within
a polymeric intermediate leads to emergence of a new
growth mode, we are able to explore a much broader
region of parameter space, and show that these appar-
ently contrasting scenarios are in fact different limits of
the same underlying reaction scheme. In addition, we
find that these previously unexplored regions contain rich
phase behavior which is not anticipated based on the be-
havior observed in the limits. Therefore, our model has
the capacity to explain a wide variety of ‘poorly behaved’
experimental or physiological systems which are not de-
scribed by existing models, such as those with mixed in-
termediates or low concentration-dependence (Sec. IV.
B. & C.). Moreover, by classifying existing two-step
nucleation models in the context of our phase diagram
(Fig. 3(a)), we have shown that these models occupy dis-
parate regions of phase space which can only be united
by considering the competitive dynamics accounted for
by µ/D and ζ. Therefore, while our model still does not
describe some of the more complex scenarios that have
been suggested [23], we have shown that explicit conver-
sion dynamics are essential features of a general model
of two-step biopolymer nucleation. We thus believe that
our study represents a crucial step towards such a model.
C. Biological importance of the nonequilibrium
critical point
In addition to generalizing existing models, the inclu-
sion of an explicit conformational conversion process al-
lows our model to predict a nonequilibrium critical point.
While critical points have previously been described in
biopolymer systems, the possibility of nonequilibrium
criticality has largely been overlooked. Instead, the most
commonly suggested critical point is the critical micel-
lar/oligomer concentration (CMC) [52, 77, 87], which is
the concentration at which the free monomer and inter-
mediate are in local equilibrium, such that m0 = k
−
1 /k
+
1 .
CMC models typically assume that formation of interme-
diates causes rapid depletion of the free monomer, so that
k−1 /k
+
1 represents an upper limit on the free monomer
concentration; as a result, saturation behavior occurs.
In this paper, we consider a different scenario. We fo-
cus primarily on the case where the free monomer de-
pletes slowly, as occurs in physiological circumstances
where there is a monomer source, or in many experi-
mental situations [88–91]. Thus, while our basic model
(Fig. 1) has the required processes to produce a CMC-
type effect, we are primarily interested in the case where
the free monomer is supersaturated with respect to the
intermediate (m0 > k
−
1 /k
−
1 ), and thus out of local equi-
librium. Under these circumstances, a second critical
point emerges at m0 = (k
−
1 + kp)/k
+
1 (Fig. 3 & 5), at
a higher concentration than the CMC. On our nonequi-
librium phase diagram (Fig. 3a), the CMC would mani-
fest as a vertical line (ie. constant µ/D) situated to the
left of the nonequilibrium critical point. The difference
in concentration between these two points will be given
by kp/k
+
1 . Although we set k
−
1 = 0 in our simulations
to focus primarily on the nonequilibrium critical point,
our mathematical analysis is valid for more general k−1
subject to the condition that destabilization of interme-
diates is negligible. Thus, the CMC and the nonequi-
librium critical point described in this paper are com-
patible so long as the concentration difference between
the two is sufficiently large. This situation is highly rel-
evant to nonequilibrium scenarios where the dissociation
of monomers from the intermediates is relatively slow, as
occurs in Alzheimer’s and Parkinson’s diseases [89–91].
In cases where kp ≪ k
−
1 , the CMC and nonequilibrium
critical point will become close to one another on the
phase diagram, and the presence of two non-negligible
absorbing boundaries in Eq. (1) will further complicate
the dynamics of self-assembly and conversion. A rigor-
ous analysis of this effect is both mathematically involved
and outside the scope of this paper, and so has been left
as a subject for future work.
It is interesting to note that in cases where physio-
logical and experimental systems exhibit slow variation
in free monomer levels over time, the phase behavior of
biopolymer self-assembly will vary accordingly. Experi-
mental systems are likely to exhibit a monotonic deple-
tion of the free monomer. In this case, µ/D will decrease
over time, causing the system to pass the nonequilib-
rium critical point en route to the CMC. The forma-
tion of stable polymers due to growth mode switching
will then cause further monomer depletion, resulting in
either destabilization or switching of the remaining in-
termediates. Thus, accelerated growth mode switching
will occur when the free monomer concentration passes
the nonequilibrium critical point at m0 = (k
−
1 + kp)/k
+
1 ,
with destabilization of the remaining intermediates oc-
curring shortly after. This sort of behavior has been ob-
served for the amyloid-β (Aβ) peptide. Under conditions
of high supersaturation, Chimon et al. [7] described the
formation of large, spheroidal intermediates by Aβ, sim-
ilar to those discussed in Sec. V. A. Over time, these
intermediates progressively acquired secondary structure
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content similar to the stable polymeric phase, but grow-
ing, stable polymers only appeared following depletion of
the free monomer. This behavior is strongly indicative
of a transition from the competitive switching regime to
the cooperative regime, as described by our model.
The biological implications of the nonequilibrium crit-
ical point extend beyond the biopolymer self-assembly
process itself. The rapid change in steady-state behavior
when µ/D ≈ 0 (Fig. 6) means that small changes in free
monomer concentration or the physicochemical environ-
ment will have a pronounced effect on the population of
intermediates. This provides a way for biological systems
to rapidly switch between producing stable polymers and
metastable intermediates with distinct biological activity.
This sort of switch-like regulation is typical of biological
systems [68, 92], and may for example reflect the impor-
tance of controlling the population of potentially toxic
species in the assembly of amyloids [93]. Thus, while pre-
vious work is restricted to specific sets of conditions, our
model encompasses a much wider context. This makes it
possible to predict the response of the system to a wide
range of stimuli, including changes in internal conditions
during the course of a reaction or external stimuli such as
mutations and temperature changes, and to interpret the
possible role that particular variations in self-assembly
conditions play in healthy functioning and disease.
Biological systems are typically maintained far-from-
equilibrium, with free monomer concentrations often
highly supersaturated in relation to their respective poly-
mers [88]. However, existing models of two-step biopoly-
mer nucleation neglect the dynamics which arise under
these nonequilibrium conditions. The requirements for
criticality are relaxed under nonequilibrium conditions,
and many of these neglected dynamics have the potential
to produce complex, biologically relevant behaviors, such
as we observe in our IP model. As discussed above, these
behaviors may explain experimental observations which
are not predicted by existing models, and rationalize the
role of physiological conditions in human disease. As a
result, we propose that the role of nonequilibrium criti-
cal phenomena in physiological biopolymer self-assembly
has been severely underestimated.
D. Relationship to autocatalytic secondary
nucleation
The model developed here can be applied to any two-
step biopolymer nucleation process. A fundamental as-
pect of our model is its ability to predict mixed inter-
mediates consisting of self-assembled monomers in two
distinct conformations, resulting in diverse intermediate
morphologies. Conversion of a self-assembled monomer
from the metastable type-1 state to the stable type-2
state occurs either non-autocatalytically, with rate kc, or
autocatalytically with rate kc+kp. Thus, the stable phase
is able to initiate locally within the intermediate, and
then propagate autocatalytically to the active end. This
type of intramolecular structural propagation has been
extensively documented in the biochemical literature in
models of multi-subunit proteins [7, 15, 24, 26, 27, 94],
and is responsible for the nonequilibrium criticality that
our model exhibits.
A different type of autocatalysis which is often dis-
cussed in models of biopolymer nucleation is secondary
nucleation, the process by which the surface of an ex-
isting stable biopolymer catalyzes the formation of ad-
ditional biopolymers by heterogeneous nucleation [95–
98]. Thus, while the proposed IP mechanism can be
considered a form of intra-polymer autocatalysis, sec-
ondary nucleation is an example of inter-polymer auto-
catalysis. Secondary nucleation has been used to explain
features such as exponential (M2(t) ∝ exp(κt)) rather
than quadratic (M2(t) ∝ t
2) accumulation of the stable
phase, and the formation of significant concentrations of
toxic intermediates during the ‘growth phase’ (ie. when
t ≈ τinf) [97]. Given the prominence of secondary nucle-
ation models in the protein polymerization literature, it
is pertinent to question how they are mechanistically re-
lated to our IP model. At the microscopic level, the pro-
cess of secondary nucleation results from the alignment
of free monomers to the surface of the mature biopoly-
mer [99]. In the context of our model, this alignment
could promote initiation of type-1 polymers which then
detach from the mature polymer and independently un-
dergo growth mode switching. This would manifest as an
increase in the initiation rate vn. There is also the possi-
bility that interactions between conformationally ordered
monomers in the stable phase and disordered monomers
in the nascent intermediate promote ordering of the lat-
ter. This would create a more tightly coupled process in
which conversion and propagation are accelerated, result-
ing in an increase in kc and kp. Thus, it is possible that
the IP mechanism and secondary nucleation share a com-
mon mechanistic basis, and are simply different examples
of a common tendency for autocatalytic conformational
change induced by interactions between monomers. All
these effects are easy to incorporate into the framework
of our IP model, and we anticipate that future studies
which combine the IP mechanism with inter-polymer au-
tocatalysis may be able to gain deeper insights into the
microscopic mechanism of secondary nucleation.
E. Competing dynamics can explain low
concentration-dependences
One of the key experimental validators for biopolymer
assembly models is their ability to accurately describe
the concentration-dependence of the process and relate
this to theory [5, 23, 32, 33, 40, 55, 56, 97, 100, 101].
The Oosawa model [32, 33] was first to ascribe a physical
meaning to the value of γ (Eq. (25)), the scaling expo-
nent for the concentration-dependence of accumulation
of the stable polymer phase (Sec. IV. C.). The Oosawa
model predicts that γ = nc/2, where nc is the effective
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order of nucleation and often represents the minimum
size for a polymer to be stable or metastable (ie. j0) [42].
While nc is often interpreted as reflecting the number of
monomers within the critical nucleus (n∗ = nc−1) [102],
which is the least stable species during the self-assembly
pathway, this explanation has been challenged by the
widespread observation of γ < 1 [55]. Such low values
of γ would imply n∗ < 1, which is physically implausible
[56]. In addition, many biopolymer systems with higher γ
still exhibit much lower concentration-dependences than
would be expected, based on biophysical predictions of
their n∗ [20, 23, 103]. Some authors have proposed
that saturation effects, such as the presence of a sat-
urable catalytic surface which induces heterogeneous nu-
cleation, may explain the low concentration-dependences
[53, 54, 104]. Indeed, γ < 1 is generally observed under
conditions where γ appears to saturate with increasing
monomer concentration. However, under some exper-
imental conditions the concentration-dependence drops
further to γ < 0.5 [55]. This is not only incompatible
with the Oosawa model, but it also occurs under cir-
cumstances where secondary nucleation remains active,
meaning it is incompatible with saturation models. To
our knowledge, the nucleation-conversion-polymerization
(NCP) [21] model is the only model in the literature
which produces low γ without invoking a saturation ef-
fect. In the NCP model, low γ values are explained in the
context of a ‘cascade nucleation system’, where sequential
conversion of N−1 pre-fibrillar intermediates results in a
concentration-dependence of nc/(N + 1) ≤ γ ≤ nc/2. In
this model, although the number of intermediate types
can be infinite, their conversion occurs as a single-step
process without considering the underlying dynamics,
and the intermediates do not exhibit a growth process.
As a result, the conversion mechanism of an NCP in-
termediate corresponds to the scenario predicted at the
point (µ/D, ζ) = (−2, 0) on our nonequilibrium phase
diagram (Fig. 3(a)).
The IP mechanism proposed here generalizes the con-
version mechanism considered in the NCP model to ex-
plicitly consider the dynamics by which intermediates
grow and individual monomers convert. As a result, our
model makes predictions regarding the pre-steady and
steady-state scaling behaviors of intermediates and ma-
ture polymers which can easily be generalized to the case
of multiple intermediates in the same manner as the NCP
model. However, the inclusion of additional dynamics al-
lows our model to explore a broader region of parameter
space, leading to our observation of sharp changes in γ
near the critical point (Fig. 5(b) & (c)). This results in lo-
cal depression of the concentration-dependence, which is
more pronounced and occurs more abruptly at higher ζ.
High ζ values correspond to systems in which autocatal-
ysis plays a dominant role in conformational conversion,
and can be achieved on comparatively modest free energy
scales (Sec. IV. A.). This reduction in concentration-
dependence allows our far-from-equilibrium model to vi-
olate constraints on the concentration-dependence of ex-
isting models over a broad range of µ/D values, and this
effect is likely to be further enhanced when saturation
effects are also active. Under many experimental condi-
tions, a value of γ < 1 is thus expected, and is simply a
result of the competing dynamics. In this study, the com-
peting processes are polymerization of the metastable
intermediate, and propagation of the stable conforma-
tional state through this intermediate. However, models
which explore other nonequilibrium dynamics are also
likely to produce such an effect. Therefore, our work
highlights the potential that far-from-equilibrium self-
assembly models with competing dynamics have to re-
solve outstanding issues relating to low concentration-
dependences.
F. Interpretation of the nucleus size
Fig. 6(c) shows how γ varies with µ/D for different
ζ values. While both µ/D and ζ are likely to depend
on the physicochemical environment under which self-
assembly occurs, and the underlying properties of the
biopolymer system, µ/D exhibits an additional depen-
dence on the free monomer concentration m0, which can
easily be varied in experimental contexts. It is useful to
note that different ζ values result in highly characteristic
changes in concentration-dependence (Fig 6(c)), so that
the ζ value intrinsic to a particular biopolymer system
can be determined by experimentallly varying µ/D and
measuring the changing concentration-dependence of as-
sembly of the stable polymer. Thus, while it is possible
to determine nc from the values of γ observed in the lim-
its where µ/D → ±2, our model predictions provide an
easier alternative. Instead, we anticipate that it will be
possible to determine nc and ζ from the characteristic
curve shape with which γ varies at intermediate values
of µ/D. This may be preferable as it eliminates the need
to explore extreme values of µ/D, which is challenging
due to lack of sensitivity of experimental methods at low
concentrations, and the likely presence of additional com-
peting processes at high concentrations. This approach
can also be generalized to cases similar to the NCP model
[21] in which multiple intermediates are present. In this
scenario, we would typically expect the Oosawa behav-
ior (γ = nc/2) to be recovered in the µ/D → −2 limit,
and the NCP-type behavior (γ = nc/(N + 1)) to be re-
covered in the µ/D → 2 limit, as we have observed in
Sec. IV. C. The inclusion of extra intermediates would
also be expected to introduce additional critical points,
which could be experimentally observable.
It is also important to note that, while our current
model identifies nc as being equal to the minimum size
of a metastable intermediate j0, future models which con-
sider additional complexities of the conversion dynamics
may arrive at different interpretations for nc. For ex-
ample, a previous coarse-grained simulation study [22]
which investigated a scenario similar to our cooperative
switching regime identified nc with the minimum size
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at which conversion can initiate within an intermediate,
rather than the absolute minimum size of an intermedi-
ate. While we take these sizes to be the same in our
model, future work which treats these quantities as dif-
ferent may provide analytical justification for this result.
VI. CONCLUSIONS
We have developed a minimal model of two-step
biopolymer nucleation which accounts for conformational
conversion of metastable intermediates by an initiation-
propagation (IP) mechanism. In our framework, the sta-
ble polymer phase initiates locally within the intermedi-
ate, and propagates by autocatalytic nearest-neighbor in-
teractions between the assembled monomers. This mech-
anism is well-supported by experimental studies showing
progressive ordering of intermediates on slow timescales
[7, 15, 24–27], and computational studies suggesting an
autocatalytic mechanism for structural conversion of the
monomers [20, 24, 28, 29]. The inclusion of conforma-
tional ordering on timescales comparable to condensa-
tion of the intermediates causes our model to exhibit
rich dynamics and a nonequilibrium critical point, which
are not predicted by models with an implicit ordering
step [19–23]. Furthermore, by explicitly considering the
dynamics of conformational conversion, our framework
unifies existing models, and shows that their apparently
unconnected behaviors occur as different limits of a sin-
gle underlying mechanism. The IP mechanism has the
potential to explain a wide variety of experimental be-
haviors which are not predicted by existing models, such
as the formation of large, conformationally mixed inter-
mediates [6, 7, 14, 15], and nucleation of the stable poly-
mer phase at a rate independent of the free monomer
concentration [55]. In our model, these phenomena arise
naturally as a result of the competing dynamics of self-
assembly and conversion, resolving the apparent para-
dox that concentration-independent nucleation rates sug-
gested critical nuclei with a non-physical size [56].
Biopolymer nucleation intermediates are responsi-
ble for toxicity in a huge range of human diseases
[16, 18, 71–74], and the nonequilibrium critical point
predicted by our model may explain the extreme
sensitivity of many polymerization disorders to small
changes in self-assembly conditions [105–107]. As a
result, our model provides a deeper understanding of
the origin of these toxic intermediates, and suggests
promising therapeutic strategies to treat diseases caused
by their formation. Moreover, future theoretical studies
which build on the results presented here are likely to
yield analytical solutions for the size distribution and
composition of nucleation intermediates, which will
provide a powerful tool in therapeutic development.
Biopolymers are also increasingly exploited by materials
scientists [108–110], and the development of a general
model of their nucleation will allow us to regulate their
formation and prevent unwarranted side reactions. In
this paper, we have shown that explicit conformational
conversion dynamics, such as those addressed by our
initiation-propagation mechanism, are essential to such
a theory. We thus believe that our work represents
a crucial step towards a general theory of two-step
biopolymer nucleation, with important implications for
both experiments and human disease.
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